• Aucun résultat trouvé

[PDF] Top 20 Chimerism and outcomes after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning

Has 10000 "Chimerism and outcomes after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning" found on our website. Below are the top 20 most common "Chimerism and outcomes after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning".

Chimerism and outcomes after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning

Chimerism and outcomes after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning

... 1 Transplantation Biology Programme, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; 2 Department of Hematology, University of Lie`ge, Lie`ge, Belgium and 3 Department ... Voir le document complet

11

Recombinant human erythropoietin therapy after allogeneic hematopoietic cell transplantation with a nonmyeloablative conditioning regimen: low donor chimerism predicts for poor response.

Recombinant human erythropoietin therapy after allogeneic hematopoietic cell transplantation with a nonmyeloablative conditioning regimen: low donor chimerism predicts for poor response.

... sTfR, and retic- ulocytes were normalized relative to their value on the day of ...Unpaired and paired Student’s t-tests as well as two-way ANOVA (using EPO group and time as variables) were used to ... Voir le document complet

10

Elevations of tumor necrosis factor-receptor-1 at day 7 and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning

Elevations of tumor necrosis factor-receptor-1 at day 7 and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning

... ratio and acute GVHD Acute GVHD of grades II, III, and IV was observed in 28, 8, and 9 patients, ...their conditioning regimen experienced grades II–IV acute GVHD, whereas 37 of 88 patients ... Voir le document complet

7

Allogeneic hematopoietic stem cell transplantation in solid organ transplant recipients: a retrospective, multicenter study of the EBMT

Allogeneic hematopoietic stem cell transplantation in solid organ transplant recipients: a retrospective, multicenter study of the EBMT

... years after alloSCT is only 40%, which is mostly due to mortality within 1 year of ...months, and it remained stable at 33% 12 months after the first ...months after alloSCT, clearly indicates ... Voir le document complet

10

Preemptive cellular immunotherapy after T-cell-depleted allogeneic hematopoietic stem cell transplantation.

Preemptive cellular immunotherapy after T-cell-depleted allogeneic hematopoietic stem cell transplantation.

... T-Cell–Depleted Nonmyeloablative Stem Cell Transplantation Followed by Preemptive DLI Several studies have now shown that PBSC transplan- tation after a reduced-intensity ... Voir le document complet

9

Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation (HSCT)

Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation (HSCT)

... (fludarabine) and control- ling the malignancy (alkylating agents) before the oc- currence of GVT effects (reviewed in 6 ...pancytopenia and organ damages can be observed with these regimens but have ... Voir le document complet

7

What is the Role for Regulatory T-Cells after Nonmyeloablative conditioning

What is the Role for Regulatory T-Cells after Nonmyeloablative conditioning

... stem cell transplantation (SCT) is applied in patients with hematological malignancies who may ben- efit from allogeneic transplantation but lack an HLA-matched do- ...T-cells, and al- ... Voir le document complet

2

Outcomes following hematopoietic stem cell transplantation in patients treated with standard chemotherapy with or without gemtuzumab ozogamicin for acute myeloid leukemia

Outcomes following hematopoietic stem cell transplantation in patients treated with standard chemotherapy with or without gemtuzumab ozogamicin for acute myeloid leukemia

... improved outcomes with fractionated-dose gemtuzumab ozogamicin (GO) combined with standard chemotherapy ...post-transplant outcomes and occurrence of hepatic veno-occlusive disease/sinusoidal ... Voir le document complet

5

T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation.

T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation.

... Allogeneic hematopoietic stem-cell transplantation (allo- HSCT) remains the only curative treatment for several he- matologic malignancies ...younger and fitter ...relapses after ... Voir le document complet

9

Scoring System Based on Post-Transplant Complications in Patients after Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome: A Study from the SFGM-TC

Scoring System Based on Post-Transplant Complications in Patients after Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome: A Study from the SFGM-TC

... Patients and donor characteristics, transplantation modalities and early complications that occurred within 100 days post- transplant were taken into ...The following variables were chosen: ... Voir le document complet

8

What role is there for antithymocyte globulin in allogeneic nonmyeloablative canine hematopoietic cell transplantation?

What role is there for antithymocyte globulin in allogeneic nonmyeloablative canine hematopoietic cell transplantation?

... blood and 50% in the lymph ...6 after initiation of therapy and became undetectable by day 13 as a result of canine antibody responses to ...prolonged allogeneic skin graft survival to 14 days ... Voir le document complet

10

What Is The Role For Regulatory T-Cells After Nonmyeloablative Conditioning?

What Is The Role For Regulatory T-Cells After Nonmyeloablative Conditioning?

... Barts and the London School of Medicine, London, United Kingdom Introduction: Long-term remissions have been observed follow- ing allogeneic hematopoietic stem cell transplantation ... Voir le document complet

2

Salvage use of allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning from unrelated donors in multiple myeloma. A study by the plasma cell disorders subcommittee of the european group for blood and marrow transplant chron

Salvage use of allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning from unrelated donors in multiple myeloma. A study by the plasma cell disorders subcommittee of the european group for blood and marrow transplant chronic malignancies working party

... (allo-HSCT) and its combination with potent anti-myelo- ma agents, especially if high-risk features are present at ...elotuzumab and ixazomib in the context of relapse with very promising ...increasing, ... Voir le document complet

4

What is the Contribution of Host-Derived CMV Immunity after Allogeneic Transplantation following Non-Myeloablative Conditioning?

What is the Contribution of Host-Derived CMV Immunity after Allogeneic Transplantation following Non-Myeloablative Conditioning?

... grafts following nonmyeloablative ...assessing chimerism levels among CMV-specific CD8+ T cells around days 40, 100 and 180 after allo-HCT in a cohort of 24 patients given ... Voir le document complet

1

Prediction of Allogeneic Hematopoietic Stem-Cell Transplantation Mortality 100 Days After Transplantation Using a Machine Learning Algorithm: A European Group for Blood and Marrow Transplantation Acute Leukemia Working Party Retrospective Data Mining Stud

Prediction of Allogeneic Hematopoietic Stem-Cell Transplantation Mortality 100 Days After Transplantation Using a Machine Learning Algorithm: A European Group for Blood and Marrow Transplantation Acute Leukemia Working Party Retrospective Data Mining Study

... (ellipses) and decision nodes ...node and is inversely correlated with predictive ...values), and the cumulative score is ...the following features (plotted as black arrows on the tree): ... Voir le document complet

10

Thymic Recovery After Allogeneic Hematopoietic Cell Transplantation with Nonmyeloablative Conditioning Might Be Limited to Patients Younger Than 60 Years of Age.

Thymic Recovery After Allogeneic Hematopoietic Cell Transplantation with Nonmyeloablative Conditioning Might Be Limited to Patients Younger Than 60 Years of Age.

... sjTREC/ml and the recipient's age ...1 and 2 years after transplantation in patients 50 (n=23; ...P=0.02 and P=0.04, respectively), and in those 51-60 years of age (n=35; ... Voir le document complet

2

Upfront allogeneic stem cell transplantation after reduced-intensity/nonmyeloablative conditioning for patients with myelodysplastic syndrome : a study by the Société Française de Greffe de Moelle et de Thérapie Cellulaire

Upfront allogeneic stem cell transplantation after reduced-intensity/nonmyeloablative conditioning for patients with myelodysplastic syndrome : a study by the Société Française de Greffe de Moelle et de Thérapie Cellulaire

... blasts and/or reappearance of major myelodysplastic features associated with cytopenia (or worsening of previous cytopenia) and evidence of autologous reconstitution when chimerism was ...(GVHD) ... Voir le document complet

7

Allogeneic hematopoietic stem cell transplantation (HSCT) after reduced intensity conditioning

Allogeneic hematopoietic stem cell transplantation (HSCT) after reduced intensity conditioning

... t Allogeneic hematopoietic stem cell transplantation (HSCT) following myeloablative (con- ventional) conditioning regimen is associated with a high incidence of ... Voir le document complet

7

Current roles for allogeneic hematopoietic cell transplantation following nonmyeloablative or reduced-intensity conditioning.

Current roles for allogeneic hematopoietic cell transplantation following nonmyeloablative or reduced-intensity conditioning.

... Since allogeneic HCT has been the only curative treatment for MDS, 37 it is not surprising that several reports address the effi cacy of nonablative HCT for ...Ho and associates reported results in 62 MDS ... Voir le document complet

15

Allogeneic Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning

Allogeneic Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning

... although nonmyeloablative enabled sustained engraftment of transplanted allogeneic hematopoietic cells in patients with advanced leukemia ...cated, and all patients eventually ...the ... Voir le document complet

26

Show all 10000 documents...